TY - JOUR T1 - Risk Factors for Cerebral Palsy in Brazilian Children: A Case-Control Study JF - medRxiv DO - 10.1101/2020.12.01.20242248 SP - 2020.12.01.20242248 AU - Marcus Valerius da Silva Peixoto AU - Andrezza Marques Duque AU - Allan Dantas dos Santos AU - Shirley Verônica Melo Almeida Lima AU - Caíque Jordan Nunes Ribeiro AU - Silvia Maria Voci AU - Susana de Carvalho AU - Marco Antônio Prado Nunes Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/12/03/2020.12.01.20242248.abstract N2 - Background Cerebral palsy is the main cause of physical disability in childhood.Objectives This study analyzed prenatal and perinatal risk factors that contribute to cerebral palsy in Brazilian children.Methods A case-control study was conducted with 2- to 10-year-old children in the city of Aracaju, Sergipe, Brazil. The cases were population-based, selected from the Primary Health Care services. The controls were selected from the database of the Brazilian Live Births Information System. Controls were paired with cases by gender, year, and hospital of birth.Results A total of 570 participants (114 cases and 456 controls) were studied. Most of the participants were male, with bilateral spastic cerebral palsy. Among the prenatal factors examined, the presence of congenital anomalies was significantly different between cases and controls (OR = 54.28, [95% CI 12.55, 234.86]). The analysis of perinatal factors revealed significant differences between cases and controls in low birth weight (OR = 3.8, [95% CI 2.34, 6.16]), preterm birth (OR = 2.31, [95% CI 1.41, 3.80]), and low Apgar scores (OR = 14.73, [95% CI 5.27, 41.15]).Conclusions The main prenatal and perinatal factors associated with cerebral palsy in our population were congenital anomalies, low Apgar scores, low birth weight, and preterm birth. The perinatal period had more risk factors, demanding a deeper study of their causes and of possible preventive measures.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors have no relevant financial relationships for this article to disclose.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The research was approved by the Federal University of Sergipe Research Ethics Committee (opinion number 1.177.455) which abides by the ethical principles of the Brazilian National Council of Ethics in Research (Conselho Nacional de Etica em Pesquisa do Brasil - CONEP) and the Declaration of Helsinki.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesI declare that the responsible researcher and the research team undertake to make the data available for eventual needs without identifying the participants. ER -